HIV-associated dementia presenting predominantly with clinical motor deficits: A case report

Laura McLean1, Stephen Aradi2, Roy Waknin3

  • 1University of South Florida, Morsani College of Medicine, Tampa, FL 33612, USA.

Insights

HIV-associated dementia typically affects older adults. This case highlights HIV-associated dementia presenting with motor symptoms in a young patient, emphasizing the need for broader diagnostic considerations.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Geriatrics

Background:

  • HIV-associated dementia (HAD) is a neurocognitive disorder affecting individuals with Human Immunodeficiency Virus.
  • It typically manifests as a subcortical dementia with cognitive impairments in concentration, attention, and memory.
  • Motor and mood changes are less common but significant diagnostic features.

Observation:

  • This report details a unique case of HAD in a 29-year-old male.
  • The patient presented with progressive weakness in the lower extremities and significant ambulation difficulties.
  • This presentation deviates from the typical cognitive-first presentation in older individuals.

Findings:

  • The case illustrates that HIV-associated dementia can present primarily with motor deficits, even in young patients.
  • This atypical presentation underscores the importance of considering HAD in younger individuals with unexplained neurological symptoms.
  • Early diagnosis and treatment are crucial for managing HAD and improving patient outcomes.

Implications:

  • This case broadens the understanding of HAD's clinical spectrum beyond cognitive decline.
  • It suggests that neurological assessments for HIV patients should include evaluation for motor impairments, regardless of age.
  • Recognizing atypical presentations of HAD is vital for timely intervention and management in diverse patient populations.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
700
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
164
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
371
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
155